drugset / Trial / NCT00120237
Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
Completed
1600 enrolled
Gynuity Health Projects
Aga Khan Health Services · collabAga Khan University · collabFamily Care International · collabThe Aga Khan Foundation · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 600 ug | Oral |